Novel therapies targeting the endothelium in sickle cell disease. - Wikidata - awgldk - TriplyDB

Novel therapies targeting the endothelium in sickle cell disease.

Novel therapies targeting the endothelium in sickle cell disease.

http://www.wikidata.org/entity/Q37930655

about

Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.

P2860

Q37178468-98E290E1-2806-4F48-BE8E-C26AA8B6C0B1 Q39290264-0BFE27B1-4406-4063-B711-C12B3B0E39E7

P2860

Novel therapies targeting the endothelium in sickle cell disease.

http://www.wikidata.org/entity/Q37930655

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel therapies targeting the endothelium in sickle cell disease.

@en

Novel therapies targeting the endothelium in sickle cell disease.

@nl

type

label

Novel therapies targeting the endothelium in sickle cell disease.

@en

Novel therapies targeting the endothelium in sickle cell disease.

@nl

prefLabel

Novel therapies targeting the endothelium in sickle cell disease.

@en

Novel therapies targeting the endothelium in sickle cell disease.

@nl

P1433

Q37930655-CA699F3B-4169-41A3-914B-CD097A268E12

P1476

Q37930655-50DD60FC-8ADD-46A5-AD11-DA079AB38F84

P2093

Q37930655-459FB01F-6390-48C9-957F-DFDA34A805FD

P2860

Q37930655-0945F6E9-E54B-40D1-A44A-E584D6720328

Q37930655-0A54370C-122A-45BA-92F4-14A4DD699481

Q37930655-0F23F037-8D91-44B8-AA22-06F9F5F8892D

Q37930655-10B9FE7F-A6A8-40C3-A100-D5447E5DF173

Q37930655-15EB04C7-EE80-4FE3-8881-95D7A6EE5944

Q37930655-192838C1-03CA-47D4-B910-D376DCF3F63B

Q37930655-193B06C5-FDC7-4AAA-93B2-4AF61259409D

Q37930655-19CDD1E2-C1ED-43A8-9C14-2BEA39F4DD56

Q37930655-2215A1D6-D494-46D1-A42D-7CA9BBC0FFE0

Q37930655-270B5AD0-BEAF-470E-834D-B68AC38038EE

P304

Q37930655-082C0E77-1A26-45C4-9F94-B60396599BA6

P31

Q37930655-54CBB574-7F00-4358-A67A-4DC288C00697

P356

Q37930655-690B3227-2924-4E66-896E-0B05169C2D79

P433

Q37930655-050CCEBB-A454-4922-B939-530BAC2A3851

P478

Q37930655-55BD55EE-2EA9-4BB5-9479-B6104B7E8E6F

P577

Q37930655-C7DEBCE1-97BC-4E77-81B0-04C231B950C7

P698

Q37930655-DB2C2A0F-E301-4D4C-B1C6-1CA13C9AFDDF

P921

Q37930655-4EDB6744-2475-4820-81BB-90C07493AFDF

Q37930655-8FA5DDB8-80C1-43B6-A0E2-FDE22C48B32E

P356

03630269.2011.606482

P1433

P1476

Novel therapies targeting the endothelium in sickle cell disease.

@en

P2093

Carolyn C Hoppe

http://www.w3.org/2001/XMLSchema#string

P2860

Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease

L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells

Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease

Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.

Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease.

Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

P304

530-546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03630269.2011.606482

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21910600

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease